GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » Price-to-Free-Cash-Flow

Cordlife Group (SGX:P8A) Price-to-Free-Cash-Flow : 5.19 (As of Jun. 07, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group Price-to-Free-Cash-Flow?

As of today (2024-06-07), Cordlife Group's share price is S$0.14. Cordlife Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03. Hence, Cordlife Group's Price-to-Free-Cash-Flow Ratio for today is 5.19.

The historical rank and industry rank for Cordlife Group's Price-to-Free-Cash-Flow or its related term are showing as below:

SGX:P8A' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.44   Med: 37.59   Max: 181.43
Current: 5.18

During the past 12 years, Cordlife Group's highest Price-to-Free-Cash-Flow Ratio was 181.43. The lowest was 4.44. And the median was 37.59.

SGX:P8A's Price-to-Free-Cash-Flow is ranked better than
91.57% of 83 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.98 vs SGX:P8A: 5.18

Cordlife Group's Free Cash Flow per Share for the six months ended in Dec. 2023 was S$0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was S$0.03.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Cordlife Group was 28.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -22.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 9.30% per year.

During the past 12 years, Cordlife Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 51.00% per year. The lowest was -40.40% per year. And the median was -17.90% per year.


Cordlife Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cordlife Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group Price-to-Free-Cash-Flow Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.37 6.93 12.90 15.24 11.67

Cordlife Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.90 - 15.24 - 11.67

Competitive Comparison of Cordlife Group's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Cordlife Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Price-to-Free-Cash-Flow falls into.



Cordlife Group Price-to-Free-Cash-Flow Calculation

Cordlife Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.14/0.027
=5.19

Cordlife Group's Share Price of today is S$0.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cordlife Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was S$0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Cordlife Group  (SGX:P8A) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Cordlife Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cordlife Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group (SGX:P8A) Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines